HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VATS versus intrapleural streptokinase: A prospective, randomized, controlled clinical trial for optimum treatment of post-traumatic Residual Hemothorax.

AbstractBACKGROUND:
Post-traumatic residual haemothorax (RH) is common and carries significant morbidity. However, its optimal treatment is not clear.
AIM:
The aim of this study was to find the extent of this problem and the choice of treatment between VATS and intra-pleural streptokinase instillation (IPSI).
MATERIAL AND METHODS:
This RCT, conducted over 18 months period, included all patients of chest trauma between 18 and 70 years of age, admitted with haemothorax or haemopneumothorax requiring inter-costal drain (ICD) insertion. 154 events of haemothorax/haemopneumothorax requiring ICD insertion were enrolled. RH was seen in 48 (31%) patients: 13 patients were excluded from RCT after refusal for treatment. Seventeen (49%) patients of remaining 35 RH cases were randomized to IPSI group and 18 (51%) patients were randomized to VATS group. The outcome parameters were resolution of RH and treatment related complications.
RESULTS:
RH resolved equally well in VATS and IPSI group [13 patients (72%) versus 12 patients (71%), respectively; continuity-adjusted p=1]. Morbidity wise no difference (p-value 0.529) was seen in the two groups.
CONCLUSION:
Post-traumatic RH is seen in 1/3rd patients and is equally well treated by VATS and IPSI.
AuthorsS Kumar, V Rathi, A Rattan, S Chaudhary, N Agarwal
JournalInjury (Injury) Vol. 46 Issue 9 Pg. 1749-52 (Sep 2015) ISSN: 1879-0267 [Electronic] Netherlands
PMID25813733 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • Fibrinolytic Agents
  • Streptokinase
Topics
  • Adult
  • Chest Tubes
  • Drainage
  • Female
  • Fibrinolytic Agents (administration & dosage)
  • Hemothorax (drug therapy, etiology, mortality, surgery, therapy)
  • Humans
  • India (epidemiology)
  • Length of Stay
  • Male
  • Prospective Studies
  • Streptokinase (administration & dosage)
  • Thoracic Injuries (complications, mortality, therapy)
  • Thoracic Surgery, Video-Assisted
  • Thrombolytic Therapy
  • Wounds, Nonpenetrating (complications, mortality, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: